The association of abdominal obesity with the incidence of in-stent restenosis and thrombosis

Shemirani, Hasan; Shirvani, Ehsan; Shirani, Babak

doi:10.48305/arya.2025.43542.3033

Document Type : Original Article

Authors

¹ Department of Cardiology, School of Medicine, Interventional Cardiology Research Center, Cardiovascular Research Institute, Nour & Ali-Asghar Hospital, Isfahan University of Medical Science, Isfahan, Iran

² Department of Cardiology, School of Medicine, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Cardiology, School of Medicine, Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/arya.2025.43542.3033

Abstract

BACKGROUND: Given the association between obesity and increased risks of cardiovascular diseases, the acceleration of atherosclerosis, and the significance of patient outcomes after percutaneous coronary intervention (PCI), this study aimed to investigate the relationship between abdominal obesity and the incidence of in-stent restenosis (ISR) or stent thrombosis (ST) following PCI.
METHODS: This cross-sectional study included 5,980 patients who underwent angioplasty at Chamran Specialty Heart Hospital from March 2023 to February 2025. Of this population, 105 patients who developed ISR or ST and returned to the hospital were evaluated. Their demographic and clinical characteristics were recorded, and waist circumference was measured to assess abdominal obesity.
RESULTS: The findings revealed that ISR and ST occurred in 66 (86.8%) and 10 (13.2%) cases, respectively, among patients with abdominal obesity, whereas in patients without abdominal obesity, these complications were observed in 25 (86.2%) and 4 (13.8%) cases, respectively (P > 0.050). Additionally, the incidence of ISR or ST was reported to occur over a longer period in patients without abdominal obesity, whereas it was observed within a shorter timeframe after PCI in patients with abdominal obesity (P < 0.05).
CONCLUSION: According to the results of this study, the prevalence of abdominal obesity was higher in patients with complications of ISR or ST after PCI. Also the incidence of ISR or ST occurred in a longer period of time in patients without abdominal obesity after PCI and in a shorter period of time after PCI in patients with abdominal obesity.

Keywords

References

1- Hoole SP, Bambrough P. Recent advances in percutaneous coronary intervention. Heart. 2020 Sep;106(18):1380-6. https://doi.org/10.1136/heartjnl-2019-315707

2- Byrne RA, Joner M, Kastrati A. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J. 2015 Dec 14;36(47):3320-31. https://doi.org/10.1093/eurheartj/ehv511

3- Nascimento Silva JS, de Barros IML, Cantarelli FL, Alves RC, Falcão FJA, Silva JMDS, et al. Predictors of coronary stent thrombosis: a case-control study. J Thromb Thrombolysis. 2018 Oct;46(3):420-6. https://doi.org/10.1007/s11239-018-1699-x

4- Nair J, Kakkar VV, Shanker J. Comparative analysis of inflammatory gene expression levels in metabolic syndrome & coronary artery disease. Indian J Med Res. 2017 Jun;145(6):777-85. https://doi.org/10.4103/ijmr.IJMR_1678_14

5- Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, et al. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012 Dec;5(6):772-82. https://doi.org/10.1161/circinterventions.111.967802

6- Sajadian M, Alizadeh L, Ganjifard M, Mardani A, Ansari MA, Falsoleiman H. Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty. Galen Med J. 2018 Jun 15;7:e961. https://doi.org/10.22086/gmj.v0i0.961

7- Liu C, Zhao Q, Zhao Z, Ma X, Xia Y, Sun Y, et al. Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome. Front Endocrinol (Lausanne). 2022 Nov 14;13:1033354. https://doi.org/10.3389/fendo.2022.1033354

8- Bernat R, Szavits-Nossan J, Trbović A, Kapov-Svilicić K, Sesto I, Sipić T. Relationship of genetic markers for atherosclerosis and long-term outcome after percutaneous coronary intervention with stenting. Coll Antropol. 2012 Dec;36(4):1385-90.

9- Konwerski M, Gąsecka A, Opolski G, Grabowski M, Mazurek T. Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review. Biology (Basel). 2022 Feb 23;11(3):355. https://doi.org/10.3390/biology11030355

10- Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc. 2014 Mar 4;3(2):e000582. https://doi.org/10.1161/jaha.113.000582

11- Schmiegelow M, Torp-Pedersen C, Gislason GH, Andersson C, Lyngbæk S, Pedersen S, et al. Relation of body mass index to risk of stent thrombosis after percutaneous coronary intervention. Am J Cardiol. 2012 Dec 1;110(11):1592-7. https://doi.org/10.1016/j.amjcard.2012.07.029

12- Jarrah M, Hammoudeh AJ, Khader Y, Tabbalat R, Al-Mousa E, Okkeh O, et al. J Int Med Res. 2018 Apr;46(4):1595-605. https://doi.org/10.1177/0300060518757354

13- Wolska-Krawczyk M, Drunck M, Behnke S, Reith W. Risk Factors for Restenosis After Stenting or Angioplasty of Vertebral Artery Origin: Results of Short-term and Long-term Follow-up. Clin Neuroradiol. 2020 Jun;30(2):355-62. https://doi.org/10.1007/s00062-019-00768-2

14- Patsa C, Toutouzas K, Tsiamis E, Tsioufis C, Spanos A, Karanasos A, et al. Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the ‘obesity paradox’ phenomenon is still apparent. Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):307-13. https://doi.org/10.1016/j.numecd.2011.05.002

15- Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006 Dec 14;444(7121):881-7. https://doi.org/10.1038/nature05488

16- Palmerini T, Della Riva D, Biondi-Zoccai G, Leon MB, Serruys PW, Smits PC, et al. Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients. JACC Cardiovasc Interv. 2018 May 14;11(9):892-902. https://doi.org/10.1016/j.jcin.2018.01.277

17- Klein LW, Nathan S, Maehara A, Messenger J, Mintz GS, Ali ZA, et al. SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis. J Soc Cardiovasc Angiogr Interv. 2023 May 18;2(4):100971. https://doi.org/10.1016/j.jscai.2023.100971

18- Gai MT, Zhu B, Chen XC, Liu F, Xie X, Gao XM, et al. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents. Lipids Health Dis. 2021 Sep 29;20(1):118. https://doi.org/10.1186/s12944-021-01553-2

19- Sarno G, Garg S, Onuma Y, Buszman P, Linke A, Ischinger T, et al. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial). Am J Cardiol. 2010 Feb 15;105(4):475-9. https://doi.org/10.1016/j.amjcard.2009.09.055

20- Feher G, Koltai K, Alkonyi B, Papp E, Keszthelyi Z, Kesmarky G, et al. Clopidogrel resistance: role of body mass and concomitant medications. Int J Cardiol. 2007 Aug 21;120(2):188-92. https://doi.org/10.1016/j.ijcard.2006.09.014

21- Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, et al. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents. Heart. 2009 Oct;95(19):1587-92. https://doi.org/10.1136/hrt.2009.172395

ARYA Atherosclerosis Journal

The association of abdominal obesity with the incidence of in-stent restenosis and thrombosis

References

References

Volume 21, Issue 2
March 2025
Pages 43-50

The association of abdominal obesity with the incidence of in-stent restenosis and thrombosis

References

References

Volume 21, Issue 2March 2025Pages 43-50

Volume 21, Issue 2
March 2025
Pages 43-50